August 6, 2025Cancer UrologyOpen Access

Analysis of survival rates and evaluation of prognostic factors in patients with bone metastases of renal cancer

View Full Paper

Ask AI

Bookmark

Overall survival rates for patients with bone metastases of renal cancer were 38% at 3 years and 23% at 5 years.
ECOG status, tumor differentiation grade, and number of metastases significantly influenced survival rates in this group.
Data from 350 patients was analyzed retrospectively, utilizing statistical tools like Kaplan–Meier curves.
Findings emphasize the importance of prognostic factors, aiding in patient management and treatment planning.

Discussion

No takes yet. Share an insight, caveat, or question.

Retrospective study analyzes survival rates in renal cancer patients, revealing key prognostic factors influencing outcomes.

Semenov et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark